Andrew Alexis, M.D., MPH
< Back to Search Results

Andrew Alexis, M.D., MPH


Profile Photo of Andrew Alexis, M.D., MPH
Accepts New Patients
Gender: Male
Language: English


Specialties and Expertise


  • General Dermatology


  • Disease of the Skin/Hair/Nails
  • Cosmetic Dermatology
  • Acne Scarring
  • Eczema
  • Keloids
  • Melasma
  • Traction Alopecia
  • Pseudofolliculitis Barbae
  • Dermatosis Papulosa Nigra
  • Acne Keloidalis Nuchae
  • Abnormal Pigmentation of Skin
  • Botox and Fillers
  • Laser Hair Removal
  • Cosmetic Laser Surgery
  • Cosmetic Skin Procedures
  • Botox and Filler Treatment
  • Laser Skin Resurfacing
  • Laser Skin Rejuvenation
  • Skin Cyst
  • Skin Lesion
  • Skin Pigmentation
  • Skin Peeling/Redness
  • Cosmetic Chemical Peel
  • Cosmetic Botox
  • Cosmetic Fillers


Andrew F. Alexis, MD, MPH is the Vice-Chair for Diversity and Inclusion for the Department of Dermatology and Professor of Clinical Dermatology at Weill Cornell Medical College in New York City. He is the former Chair of the Department of Dermatology at Mount Sinai Morningside and Mount Sinai West. Having served as Director of the first-of-its-kind Skin of Color Center for over 15 years, his work has helped to advance patient care, research, and education pertaining to dermatologic disorders that are prevalent in populations with skin of color.  

Dr. Alexis received his medical degree from Columbia University Vagelos College of Physicians & Surgeons and his Master of Public Health at Columbia University Mailman School of Public Health. He completed his dermatology residency at Weill Cornell Medicine, followed by a fellowship in dermatopharmacology at NYU Langone’s Ronald O. Perelman Department of Dermatology. 

Dr. Alexis has published more than 90 articles in peer-reviewed journals including the British Journal of Dermatology, Journal of the American Academy of Dermatology, and JAMA Dermatology among others. He has co-edited two textbooks and authored over 10 book chapters. Dr. Alexis is a frequent lecturer at national and international conferences and has been invited as a Visiting Professor or Grand Rounds speaker at many prestigious academic institutions. 

Dr. Alexis has held numerous leadership positions in professional organizations including Past President of the New York Dermatological Society, Past President of the New York Academy of Medicine Dermatology Section, Secretary/Treasurer of the Skin of Color Society and Chair of the Diversity Task Force Committee for the American Academy of Dermatology. He currently serves as Co-Chair of the Scientific Committee of the Skin of Color Society, and is a member of the Board of Directors of the American Dermatological Association and the Cicatricial Alopecia Research Foundation. 

Dr. Alexis has appeared on ABC, CBS, NBC, and FOX television news programs and has been quoted in numerous leading publications, including the New York Times, Wall Street Journal, Forbes, Vogue, Allure, and Essence. He is listed in Castle Connolly’s Top Doctors ™ and Super Doctors®


Honors and Awards

Honors and Awards

Dr. Alexis is listed in Castle Connolly’s Top Doctors ™ and Super Doctors®.


Board Certifications

  • American Board of Dermatology

Clinical and Academic Positions

  • Attending Dermatologist - NewYork-Presbyterian Hospital
  • Professor of Clinical Dermatology - Weill Cornell Medical College, Cornell University

Education and Training

  • M.P.H., Columbia University, 1999
  • M.D., Columbia University College of Physicians and Surgeons, 1999
  • B.Sc., McGill University (Canada), 1995


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna Weill Cornell Employee Managed Care Plan
  • Aetna Weill Cornell Employee PPO Plan
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • Amida Care
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - Blue Connection
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Medicaid
  • Medicare
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare - Medicare
  • United Healthcare Compass
  • VNSNY CHOICE - Medicare
  • WellCare of NY
  • WorldWide Medical

Locations and Appointments

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member:
AbbVie Inc.; Bausch Health; Cara Therapeutics; Eli Lilly and Company; Galderma S.A.; Johnson & Johnson; L'Oreal USA; LEO Pharma Inc.; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Swiss American CDMO, LLC; UCB Pharma, Inc.; Valeant Pharmaceuticals North America; VYNE Therapeutics Inc.
AbbVie Inc.; Arcutis Biotherapeutics, Inc.; Bristol-Myers Squibb Company; Dermavant Sciences, Inc.; Galderma S.A.; Janssen Global Services, LLC; LEO Pharma Inc.; Pfizer, Inc.; Sanofi-Genzyme; UCB Pharma, Inc.
Other Interest:
Canfield Scientific, Inc.; Castle Biosciences, Inc
Bristol-Myers Squibb Company; Janssen Global Services, LLC; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi US; Sanofi-Genzyme